Sarnia, Ontario, May 25, 2022 (The Globe Newswire) – Breast Cancer Society of Canada The BCSC today announced the recipients of their first-of-its-kind breast cancer research application. Researchers from across Canada were invited to submit projects last December for consideration for funding in 2022 and beyond.
In February 2021, the World Health Organization declared breast cancer to be the most frequently diagnosed type of cancer worldwide. Nearly 28,000 Canadians will be diagnosed this year. The breast cancer research projects selected for funding will aim to enhance screening, detection, accuracy of tumors and patient-reported outcomes, and enhance care for Canadians with breast cancer.
“Research has shown us that there are more than 50 types of breast cancer, each with its own unique challenges and demands,” said Kimberly Carson, CEO of Breast Cancer Society of Canada. “New funded research projects will directly impact the lives of breast cancer patients through the development of new diagnostic tools and treatment plans tailored to the individual, as patient support is no longer one-size-fits-all.”
Below are the recipients and research categories selected by BCSC for funding:
|Anand Krishnan||University of Saskatoon||treatment research||$75,000|
|Carrie Shimanko||University of Calgary||Micro-oncology research||$75,000|
|Musumi Majumdar||Brandon University, Manitoba||Examination and detection –
|Melba de Sousa||Thomson Rivers University, British Columbia||Patient reported results||$75,000|
|Jim Xiang||University of Saskatoon||Micro-oncology research||$25,000|
|Lisa Porter||University of Windsor||treatment research||$25,000|
Driven by its vision to end breast cancer, BCSC is committed to funding research projects that will have a direct impact on Canadian patients, with an emphasis on the rapid movement of research results from the laboratory bench to the bed. For example, recipient Musumi Majumder of Brandon University received $75,000 to fund breast cancer screening and detection as part of Precision Genome Research. Musumei’s research will focus on genetic contributions to patient health, disease susceptibility or resilience, and individual responses to therapeutic interventions.
The BCSC Scientific Committee is directed by funding research that supports breast cancer outcomes for Canadians through funding innovative research and personalized therapy. The goal is to be able to deliver the right cancer treatment, to the right patient, at the right dose, at the right time. The group expresses its gratitude to all applicants who submitted an application. The volume and quality of applications received were significant and the committee looks forward to funding new projects next year.
The Canadian Breast Cancer Society extends its thanks to the generous donors who have made possible breast cancer research grant proposals through their contributions.
Please visit bcsc.ca/updates for more information on research grants and other projects in progress at BCSC.
About the Breast Cancer Society of Canada (BCSC)
The Breast Cancer Society of Canada (BCSC) is a registered non-profit national charitable organization dedicated to saving lives through breast cancer research. BCSC raises money to fund patient-centered research for breast cancer diagnosis, treatment, and prevention. For more information, please visit bcsc.ca.
An accompanying image is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3f75395f-8803-4d7b-a007-bc9f20c23045